Repatha (evolocumab) - Amgen, Astellas
Serial Assessment of AI-Based Body Composition Change After 18 Months of Evolocumab Treatment: An EVOLVE Subanalysis (AHA 2026) - Sep 5, 2026 - Abstract #MDP0601; Pres time: Nov 7, 2026; 12:43 PM - 12:48 PM; Location: Moderated Digital Poster 6‚ Clinical Science Zone 1; In-Person; No abstract available 
https://eppro01.ativ.me/web/page.php?page=session&project=AHA26&id=P5311
 
Daniel Berman; Matthew Budoff; Damini Dey; John Friedman; Heidi Gransar; Donghee Han; Sean Hayes; Alan Kwan; Jacek Kwiecinski; Mark Lemley; Hyun Mark; Rebekah Park; Prediman Shah; Aakash Shanbhag; Piotr Slomka; Balaji Tamarappoo; louise thomson; Evangelos Tzolos; Jirong Yi
 
Sep 5, 2026
 
Prev Next